10Aug 2017

EXPLORATION OF GASTROINTESTINAL MICROFLORA IN FECES OF TWO MOROCCAN AUTISTIC CHILDREN: 2 CASE STUDIES.

  • Unit of Neuroscience and Applied Nutrition, Laboratory of Nutrition, Health and Environment, Department of iology, Faculty of Science, PoBox.133, Kenitra, Morocco.
  • Department of Biology, PolydisciplinaryFaculty, Sultan Moulay Sliman University, Beni Mellal, Morocco.
  • Department of Biology, Faculty of Science Ben M?Sik, Hassan II University, Driss Harti Sreet, PoBox. 7955, 20700 Sidi Othmane, Casablanca, Morocco.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The autism may be involved in microbiology disturbance and gastrointestinal health of autistic patients. In this study, the analysis of the stool specimen of the Moroccan individual with autism provides fundamental information about the overall gastrointestinal health of the patient. Abnormal intestinal microorganisms in the gastrointestinal tract are widely known to cause disease. The stool analysis included parameters for digestion absorption, cultures for bacteria and yeast, parasite testing, an inflammatory marker, short fatty acids, PH, blood presence. In addition, a questionnaire E 2 is used as to confirm the autism and to elicit intestinal problems during the first months.The gastrointestinal health status of these children is not widely disturbed. Abnormal microflora or significant aberrations in intestinal health markers are detected in the patient with autism. The information about the gastrointestinal health status leads to select an appropriate antibiotic therapy in order to decrease the autistic symptoms. The activity of antimicrobial and antifungal drugs against respectively dysbiotic flora and yeast involved namely Citrobacter freundii and Candida albicans were presented.

  1. Sekirov I, Russell SL, Antunes LC, Finlay BB (2010). Gut microbiota in health and disease. Physiol Rev.; 90: 859?904.
  2. Clemente JC, Ursell LK, Parfrey LW, Knight R(2012). The impact of the gut microbiota on human health: an integrative view. Cell.; 148: 1258?1270.
  3. Parracho HM, Bingham MO, Gibson GR, McCartney AL(1997). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005;54:987-91.
  4. Wing, L. The autistic spectrum. Lancet.;? 350:1761?1766.
  5. Shaw W, Kassen E, Chaves E(1995). Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem.41: 1094?1104
  6. Bolte E R(1998). Autism and Clostridium tetani. Med Hypotheses.; 51:133?144.
  7. Buie T, Campbell DB, Fuchs GJ, et al (2010). Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics; 125 (1):S1?18.
  8. Coury DL, Ashwood P, Fasano A, et al (2012). Gastrointestinal conditions in children with autism spectrum disorder: developing a research agenda. Pediatrics.; 130 (2):S160?8.
  9. Horbath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT (1999). Gastrointestinal abnormalities in children with autostic disorder. J Pediatr.; 135: 559-563.
  10. Rachel West DO, Roberts E, Sichel LS, Sichel J (2013) . Improvement in gastrointestinal symptoms among children with autism spectrum disorders receiving delpro?probiotis and immunomodulator formulation. J Prob Health, 1:1
  11. Tuohy KM, Probert HM, Smejkal CW, Gibson GR (2003). Using probiotics and prebiotics to improve gut health.Drug Discov Today.; 8:692-700
  12. Brook I (1995). Clostridial infection in children. J Med Microbiol.; 42: 78?82.
  13. Finegold SM, Molitoris D, Song Y. & 20 other authors (2002). Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis; 35 ( 1): S6?S16.
  14. Harchaoui H, F,? Ahami.A, Boulbaroud.S and El Hioui.M (2013). "Biochemical and Neurobiological Study of Moroccan Autists,"?Neuroscience and Medicine, Vol. 4 No. 4, 2013, pp. 271-276. doi:?10.4236/nm..44039
  15. Van Der Sluys Veer A, Brouwer J, Biemond I, Bohbouth GE, Verspaget HW, Lamers CBHW (1998).Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease. Dig Dis Sci.; 43(3):590-595.
  16. Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AAM, Cooper WH, Lee AG (1992).Measurement of Fecal Lactoferrin as a Marker of Fecal Leukocytes. J Clin Microbiol; 30:1238-1242.
  17. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB (2003): Fecal Lactoferrin is a Sensitive and Specific Marker in Identifying Intestinal Inflammation. Am J Gastroenterol.98(6):1309-1314.
  18. Kayazawa M, Saitoh O, Kojima K, Nakagawa K, Tanaka S, Tabata K, Matsuse R, Uchida K, Hoshimoto M, Hirata I, Katsu K (2002) : Lactoferrin in Whole Gut Lavage Fluid as a Marker for Disease Activity in Inflammatory Bowel Disease: Comparison with Other Neutrophil-Derived Proteins. Am J Gastroenterol. 97(2):360-369.
  19. Dugad L, Wu Z (2007) : PerformanceVerification of Lactoferrin ELISA Test Kit of Fecal Verification 104. Doctor?s Data Inc, Saint Charles, Illinois;.
  20. Kudoh K, Shimizu J, Ishiyama A, Wada M, Takita T, Kanke Y, Innami S (1999): Secretion and Excretion of Immunoglobulin A to Cecum and Feces Differ with Type of Indigestible Saccharides. J Nutr Sci Vitaminol.; 45:173-181.
  21. Nishio O, Sakae K, Ishihara Y, Isomura S, Inouye S (1992): Adenovirus Infection and Specific Secretory IgA Responses in the Intestine of Infants. Microbiol Immunol.; 36(6):623-631.
  22. Stals F, Walther F, Bruggeman CA: Faecal and Pharyngeal Shedding of Rotavirus and Rotavirus IgA in Children with Diarrhea. J Med Virol. 1984; 14:333-339.
  23. Scerpella EG, Gould SS, Mathewson JJ, DuPont HL. Methods for Detection of an Intestinal Secretory Immunoglobulin A Response to Candida spp. and Their Preliminary Application in Human Immunodeficiency Virus- Infected Patients with Chronic Diarrhea. Clin Diagn Lab Immunol. 1995; 2(2):246-248.
  24. Araki Y, Andoh A, Fujiyama Y, Itoh A, Bamba T (2002) : In vitro Alterations in Fecal Short Chain Fatty Acids and Organic Anions Induced by the Destruction of Intestinal Microflora under Hypotonic and Aerobic Conditions. Int J Mol Med.9(6):627-631.
  25. Topping DL, Clifton PM (2001). Short Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides. Physiol Reviews.; 81(3):1031-1064.
  26. MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP (2011) . Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res. 217: 47-54.
  27. Gondalia SV, Palombo EA, Knowles SR, Cox SB, Meyer D et al (2012) . Molecular characterisation of gastrointestinal microbiota of children with autism (with and without gastrointestinal dysfunction) and their neurotypical siblings. Autism Res. 5: 419-427.
  28. De Angelis M,?Piccolo M,?Vannini L, Siragusa S,? De Giacomo A,? Serrazzanetti DA et al (2013). Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified. PLoS One. 8(10): e76993.
  29. Kudoh K,?Shimizu J,?Ishiyama A,?Wada M,?Takita T,?Kanke Y,?Innami S (1999). Secretion and excretion of immunoglobulin A to cecum and feces differ with type of indigestible saccharides.J Nutr Sci Vitaminol; 45(2):173-81.
  30. Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA (2011) . Gastrointestinal flora and gastrointestinal status in children with autism?comparisons to typical children and correlation with autism severity. BMC Gastroenterol;16: 11-22.
  31. Roy CC, Kien CL, Bouthillier L, Levy E (2006) . Short-chain fatty acids: ready for prime time?. Nutr Clin Pract. 21: 351-66.
  32. Sandler RH, Finegold SM, Botle ER, Buchanan CP, Maxwell AP, Vaisanen ML, et al (2000). Short-term benefit from oral vancomycin treatment of regressive-onset autism. J child Neurol.15:429-435.
  33. Galiatsatos P, Gologan A, Lamoureux E. (2009). Autistic enterocolitis: Facts or fiction?. Can?J Gastroenterol.; 23(2): 95-98.

[Harchaoui H, Boulbaroud S, Azzaoui F-Z, Ahami A and Abousalah Y. (2017); EXPLORATION OF GASTROINTESTINAL MICROFLORA IN FECES OF TWO MOROCCAN AUTISTIC CHILDREN: 2 CASE STUDIES. Int. J. of Adv. Res. 5 (Aug). 121-128] (ISSN 2320-5407). www.journalijar.com

hakim harchaoui
. Unit of Neuroscience and Applied Nutrition, Laboratory of Nutrition, Health and Environment, Department of iology, Faculty of Science, PoBox.133, Kenitra, Morocco

DOI:

Article DOI: 10.21474/IJAR01/5042      
DOI URL: https://dx.doi.org/10.21474/IJAR01/5042

Download Full Paper

Download PDF No. of Downloads: 31 | No. of Views: 166